Sex Subgroup Analysis of Treatment Response to Lisdexamfetamine Dimesylate in Children Aged 6 to 12 Years With Attention-Deficit/Hyperactivity Disorder

被引：0
|
作者：
McGough, James J. [1 ,2 ]
Greenbaum, Michael [3 ]
Adeyi, Ben [4 ]
Babcock, Thomas [4 ]
Scheckner, Brian [4 ]
Dirks, Bryan [4 ]
Findling, Robert L. [5 ]
机构：
[1] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
[3] Capstone Clin Res, Libertyville, IL USA
[4] Shire Dev Inc, Wayne, PA USA
[5] Univ Hosp Case Med Ctr, Cleveland, OH USA
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2012年 / 32卷 / 01期
关键词：
CLINICAL-TRIALS; MODERATORS; ADHD;
D O I：
10.1097/JCP.0b013e318240dc53
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：138 / 140
页数：4
相关论文
共 50 条
  • [41] Long-term safety and efficacy of lisdexamfetamine dimesylate in children and adolescents with attention-deficit/hyperactivity disorder
    Zuddas, A.
    Banaschewski, T.
    Nagy, P.
    Soutullo, C.
    Yan, B.
    Caballero, B.
    Coghill, D.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S648 - S648
  • [42] Treatment outcomes after methylphenidate in adults with attention-deficit/hyperactivity disorder treated with lisdexamfetamine dimesylate or atomoxetine
    Joseph, Alain
    Cloutier, Martin
    Guerin, Annie
    Nitulescu, Roy
    Sikirica, Vanja
    PATIENT PREFERENCE AND ADHERENCE, 2016, 10 : 391 - 405
  • [43] Lisdexamfetamine dimesylate: a Treatment Option for Children and Adolescents with Attention Deficit/Hyperactivity Disorder in Germany and Across Europe
    Haege, A.
    Banaschewski, T.
    Dittmann, R. W.
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2015, 83 (12) : 676 - 685
  • [44] Long-term safety of lisdexamfetamine dimesylate (LDX) in adolescents with attention-deficit/hyperactivity disorder
    Findling, R.
    Childress, A.
    Cutler, A.
    Hamdani, M.
    Ferreira-Cornwell, M. C.
    Shaw, M.
    Gasior, M.
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2011, 20 (01) : S117 - S118
  • [45] LONG-TERM SAFETY AND EFFICACY OF LISDEXAMFETAMINE DIMESYLATE BY AGE SUBGROUP IN CHILDREN AND ADOLESCENTS WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER
    Coghill, D.
    Hernandez Otero, I.
    Nagy, P.
    Soutullo, C. A.
    Zuddas, A.
    Geibel, B.
    Naser, N.
    Yan, B.
    Banaschewski, T.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2016, 50 : 162 - 162
  • [46] The Efficacy and Safety Profile of Lisdexamfetamine Dimesylate, a Prodrug of d-Amphetamine, for the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adults
    Najib, Jadwiga
    CLINICAL THERAPEUTICS, 2009, 31 (01) : 142 - 176
  • [47] EFFICACY OUTCOMES IN AGE AND SEX SUBGROUPS FROM TWO CLINICAL TRIALS OF LISDEXAMFETAMINE DIMESYLATE IN THE TREATMENT OF ADULTS WITH ATTENTION-DEFICIT/HYPERACTIVITY DISORDER
    Adler, L. A.
    Dirks, B.
    Adeyi, B.
    Squires, L. A.
    EUROPEAN PSYCHIATRY, 2014, 29
  • [48] Long-Term Safety and Effectiveness of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder
    Weisler, Richard
    Young, Joel
    Mattingly, Greg
    Gao, Joseph
    Squires, Liza
    Adler, Lenard
    CNS SPECTRUMS, 2009, 14 (10) : 573 - 585
  • [49] Maintenance of Efficacy of Lisdexamfetamine Dimesylate in Adults With Attention-Deficit/Hyperactivity Disorder: Randomized Withdrawal Design
    Brams, Matthew
    Weisler, Richard
    Findling, Robert L.
    Gasior, Maria
    Hamdani, Mohamed
    Ferreira-Cornwell, M. Celeste
    Squires, Liza
    JOURNAL OF CLINICAL PSYCHIATRY, 2012, 73 (07) : 977 - 983
  • [50] Long-term safety and efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder
    Lasser, R.
    Weisler, R.
    Young, J.
    Mattingly, G.
    Gao, J.
    Adler, L.
    Squires, L.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2009, 19 : S356 - S356
12345